Document Detail

Effects of chronic hyperghrelinemia on puberty onset and pregnancy outcome in the rat.
MedLine Citation:
PMID:  15790726     Owner:  NLM     Status:  MEDLINE    
Ghrelin, the endogenous ligand of the GH secretagogue receptor, has been recently involved in a wide array of biological functions, including signaling of energy insufficiency and energy homeostasis. On the basis of the proven reproductive effects of other regulators of energy balance, such as the adipocyte-derived hormone leptin, we hypothesized that systemic ghrelin may participate in the control of key aspects of reproductive function. To test this hypothesis, the effects of daily treatment with ghrelin were assessed in rats, pair-fed with control animals, in two relevant reproductive states, puberty and gestation, which are highly dependent on proper energy stores. Daily sc injection of ghrelin (0.5 nmol/12 h; between postnatal d 33 and 43) significantly decreased serum LH and testosterone levels and partially prevented balano-preputial separation (as an external index of puberty onset) in pubertal male rats. On the contrary, chronic administration of ghrelin to prepubertal females, between postnatal d 23 and 33, failed to induce major changes in serum levels of gonadotropins and estradiol, nor did it modify the timing of puberty, as estimated by the ages at vaginal opening and first estrus. Moreover, females treated with ghrelin at puberty subsequently displayed normal estrous cyclicity and were fertile. Conversely, ghrelin administration (0.5 nmol/12 h) during the first half of pregnancy (d 1-11) resulted in a significant decrease in pregnancy outcome, as estimated by the number of pups born per litter, without changes in the number of successful pregnancies at term or gestational length. Overall, our data indicate that persistently elevated ghrelin levels, as a putative signal for energy insufficiency, may operate as a negative modifier of key reproductive states, such as pregnancy and (male) puberty onset.
R Fernández-Fernández; V M Navarro; M L Barreiro; E M Vigo; S Tovar; A V Sirotkin; F F Casanueva; E Aguilar; C Dieguez; L Pinilla; M Tena-Sempere
Related Documents :
20085916 - Cyclosporine a exposure during pregnancy in mice: effects on reproductive performance i...
4032376 - Disruption of pair bonding induces pregnancy failure in newly mated mongolian gerbils (...
17062636 - Genetic determinants modulate susceptibility to pregnancy-associated tumourigenesis in ...
18250336 - Ambient temperature predicts sex ratios and male longevity.
22877246 - Fetal heart rate in the second stage of labor, recording, reading, interpreting and act...
19959316 - Molar pregnancy-induced thyroid storm.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2005-03-24
Journal Detail:
Title:  Endocrinology     Volume:  146     ISSN:  0013-7227     ISO Abbreviation:  Endocrinology     Publication Date:  2005 Jul 
Date Detail:
Created Date:  2005-06-10     Completed Date:  2005-07-21     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0375040     Medline TA:  Endocrinology     Country:  United States    
Other Details:
Languages:  eng     Pagination:  3018-25     Citation Subset:  AIM; IM    
Department of Cell Biology, Physiology, and Immunology, Faculty of Medicine, University of Cordoba, Avenida Menéndez Pidal s/n, 14004 Cordoba, Spain.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Drug Administration Schedule
Injections, Subcutaneous
Peptide Hormones / administration & dosage,  blood*,  pharmacology
Pregnancy Outcome*
Pregnancy, Animal / blood*
Rats, Wistar
Sexual Maturation* / drug effects
Time Factors
Reg. No./Substance:
0/Ghrelin; 0/Peptide Hormones

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Three peroxisome proliferator-activated receptor isotypes from each of two species of marine fish.
Next Document:  Estrogen and estrogen receptor-{beta} (ER{beta})-selective ligands induce galanin expression within ...